PURSENNID Side Effects

5933698-7 | Gastrointestinal Necrosis
on Oct 24, 2008 Male patient from JAPAN , weighting 108.0 lb, was diagnosed with rectal cancer recurrent and was treated with Pursennid (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal necrosis. Pursennid dosage: Unk. During the same period patient was treated with LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), ELPLAT (View Elplat Review and Elplat Label ).

5260765-6 | Hyperkalaemia
Patient was taking Pursennid (View Usage). Patient had the following side effects: hyperkalaemia on Feb 26, 2007 from JAPAN Additional patient health information: Female patient , 86 years of age, was diagnosed with constipation (What is constipation?), hyperkalaemia, hypertension, cardiac failure, reflux oesophagitis, insomnia and. Pursennid dosage: . During the same period patient was treated with ARGAMATE JELLY (View Argamate Jelly Review and Argamate Jelly Label ), COZAAR (View Cozaar Review and Cozaar Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ), TAKEPRON (View Takepron Review and Takepron Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ).

5023500-2 | Blood Creatinine Increased, Nephritis Interstitial, Platelet Count Decreased
Adverse event was reported on Feb 28, 2006 by a Female patient taking Pursennid (View Usage) (Dosage: ) was diagnosed with constipation (What is constipation?), haemosiderosis, aplastic anaemia, headache (What is headache?) and. Location: JAPAN , 47 years of age, weighting 112.4 lb, After Pursennid was administered, patient had the following side effects: blood creatinine increased, nephritis interstitial, platelet count decreased. During the same period patient was treated with EXJADE (1000 Mg, Qd) (View Exjade Review and Exjade Label ), NEORAL (160 Mg, Unk) (View Neoral Review and Neoral Label ), BONZOL (100 Mg, Unk) (View Bonzol Review and Bonzol Label ), PRIMOBOLAN DEPOT INJ (View Primobolan-depot Inj Review and Primobolan-depot Inj Label ), KERORIN (1 Tablet, Daily) (View Kerorin Review and Kerorin Label ), NORSHIN (1 Pack, Daily) (View Norshin Review and Norshin Label ).

4702758-0 | Blood Pressure Decreased, Blood Pressure Immeasurable, Bradycardia, Cold Sweat, Depressed Level Of Consciousness, Heart Rate Decreased, Nausea, Shock
on Apr 08, 2005 Male patient from , 72 years of age, weighting 141.1 lb, was diagnosed with constipation (What is constipation?), pituitary tumour and was treated with Pursennid (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, blood pressure immeasurable, bradycardia, cold sweat, depressed level of consciousness, heart rate decreased, nausea (What is nausea?), shock. Pursennid dosage: 24 Mg, Unk. During the same period patient was treated with PARLODEL (2.5 Mg, Qd) (View Parlodel Review and Parlodel Label ).


4658639-4 | Blood Pressure Decreased, Blood Pressure Immeasurable, Bradycardia, Cardiogenic Shock, Cold Sweat, Depressed Level Of Consciousness, Heart Rate Decreased, Nausea
on Apr 08, 2005 Male patient from , 72 years of age, weighting 141.1 lb, was diagnosed with constipation (What is constipation?), pituitary tumour and was treated with Pursennid (View Usage). Patient had the following side effects: blood pressure decreased, blood pressure immeasurable, bradycardia, cardiogenic shock, cold sweat, depressed level of consciousness, heart rate decreased, nausea (What is nausea?). Pursennid dosage: 24 Mg, Unk. During the same period patient was treated with PARLODEL (2.5 Mg, Qd) (View Parlodel Review and Parlodel Label ).